{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:59:31Z","timestamp":1772110771523,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.cbi.2008.12.005","type":"journal-article","created":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T07:14:43Z","timestamp":1229498083000},"page":"263-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["In vitro assessment of P450 induction potential of novel chemopreventive agents SR13668, 9-cis-UAB30, and pentamethychromanol in primary cultures of human hepatocytes"],"prefix":"10.1016","volume":"179","author":[{"given":"Jonathan P.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasim K.","family":"Kabirov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izet M.","family":"Kapetanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Lyubimov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2008.12.005_bib1","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1021\/jm070040e","article-title":"Computer-aided rational drug design: a novel agent (SR13668) designed to mimic the unique anticancer mechanisms of dietary indole-3-carbinol to block Akt signaling","volume":"50","author":"Chao","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2008.12.005_bib2","unstructured":"L. Jong, W.-R. Chao, K. Amin, K. Laderoute, J. Orduna, B. Sato, G. Rice, SR13668: a novel indole derived inhibitor of phospho-Akt potently suppresses tumor growth in various murine xenograft models, AACR Meeting Abstracts, March 2004, 2004, pp. 849\u2013850."},{"key":"10.1016\/j.cbi.2008.12.005_bib3","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ejca.2005.04.016","article-title":"The chemopreventive agent development research program in the Division of Cancer Prevention of the US National Cancer Institute: an overview","volume":"41","author":"Crowell","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cbi.2008.12.005_bib4","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1158\/1535-7163.MCT-07-0120","article-title":"Targeting the AKT protein kinase for cancer prevention","volume":"6","author":"Crowell","year":"2007","journal-title":"Mol. Cancer Ther."},{"issue":"October","key":"10.1016\/j.cbi.2008.12.005_bib5","first-page":"96","article-title":"SR13668: a highly optimized AKT inhibitor based on indole-3-carbinol possesses potent oral anticancer activity, and induces G1 cell cycle arrest and apoptosis in vitro and in vivo","author":"Jong","year":"2003","journal-title":"Frontiers Cancer Prevent. Res."},{"key":"10.1016\/j.cbi.2008.12.005_bib6","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.toxlet.2007.05.283","article-title":"Preclinical toxicology and development of SR13668, a novel new candidate cancer chemopreventive agent","volume":"172S","author":"Kapetanovic","year":"2007","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2008.12.005_bib7","first-page":"641","article-title":"The low-toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and has anti-telomerase activity in human breast cancer cells","volume":"30","author":"Hansen","year":"2007","journal-title":"Int. J. Oncol."},{"issue":"18","key":"10.1016\/j.cbi.2008.12.005_bib8","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1158\/1078-0432.CCR-07-0404","article-title":"Short-term modulation of cell proliferation and apoptosis and preventive\/therapeutic efficacy of various agents in a mammary cancer model","volume":"13","author":"Christov","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cbi.2008.12.005_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3835(03)00461-0","article-title":"9cUAB30, an RXR specific retinoid, and\/or tamoxifen in the prevention of methylnitrosourea-induced mammary cancers","volume":"201","author":"Grubbs","year":"2003","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.cbi.2008.12.005_bib10","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/carcin\/bgi308","article-title":"Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers","volume":"27","author":"Grubbs","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cbi.2008.12.005_bib11","first-page":"364","article-title":"Oral toxicity study of a retinoic acid analogue, 9-cis-UAB-30, in rats","author":"Krishnaraj","year":"2005","journal-title":"Toxicologist"},{"key":"10.1016\/j.cbi.2008.12.005_bib12","first-page":"797","article-title":"Androgen antagonist activity by the antioxidant moiety of vitamin E, 2,2,5,7,8-pentamethyl-6-chromanol in human prostate carcinoma cells","volume":"2","author":"Thompson","year":"2003","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.cbi.2008.12.005_bib13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s11745-998-0244-4","article-title":"Protective effect of a vitamin E analog, phosphatidylchromanol, against oxidative hemolysis of human erythrocytes","volume":"33","author":"Koga","year":"1998","journal-title":"Lipids"},{"key":"10.1016\/j.cbi.2008.12.005_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0168-8278(97)80499-0","article-title":"Use of hepatocyte cultures for the study of hepatotoxic compounds","volume":"26","author":"Guillouzo","year":"1997","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2008.12.005_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0009-2797(99)00149-0","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin induction of cytochrome P4501A in cultured rat and human hepatocytes","volume":"124","author":"Xu","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2008.12.005_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0928-0987(01)00135-X","article-title":"Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation","volume":"13","author":"LeCluyse","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.cbi.2008.12.005_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s004410100429","article-title":"Regulation of cell morphology and cytochrome P450 expression in human hepatocytes by extracellular matrix and cell interactions","volume":"306","author":"Hamilton","year":"2001","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.cbi.2008.12.005_bib18","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2165\/00003088-200342150-00003","article-title":"Role of orphan nuclear receptors in the regulation of drug metabolizing enzymes","volume":"42","author":"Wang","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.cbi.2008.12.005_bib19","first-page":"207","article-title":"Isolation and culture of primary human hepatocytes","volume":"290","author":"LeCluyse","year":"2005","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cbi.2008.12.005_bib20","series-title":"The Isolated Hepatocyte: Use in Toxicology and Xenobiotic Biotransformation","article-title":"Cytotoxicity measures: choices and methods","author":"Tyson","year":"1987"},{"key":"10.1016\/j.cbi.2008.12.005_bib21","unstructured":"FDA, Draft Guidance for Industry \u2013 drug interaction studies: study design, data analysis, and implications for dosing and labeling, Food and Drug Administration Publication, 2006."},{"key":"10.1016\/j.cbi.2008.12.005_bib22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/dmd.31.7.815","article-title":"Perspective: the conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective","volume":"31","author":"Bjornsson","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2008.12.005_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mrgentox.2007.02.004","article-title":"Evaluation of chemopreventive agents for genotoxic activity","volume":"629","author":"Doppalapudi","year":"2007","journal-title":"Mutation Res."},{"key":"10.1016\/j.cbi.2008.12.005_bib24","first-page":"60","article-title":"Four week oral toxicity study of the retinoic acid derivative 9-cis-UAB-30, in female dogs","author":"Lindeblad","year":"2007","journal-title":"Toxicologist"},{"issue":"7","key":"10.1016\/j.cbi.2008.12.005_bib25","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1124\/dmd.106.013938","article-title":"In vitro metabolic characterization, phenotyping, and kinetic studies of 9cUAB30, a retinoid X receptor-specific retinoid","volume":"35","author":"Gorman","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.cbi.2008.12.005_bib26","first-page":"242","article-title":"Induction of CYP2C genes in human hepatocytes in primary culture","volume":"29","author":"Gerbal-Chaloin","year":"2001","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.cbi.2008.12.005_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1124\/jpet.103.058818","article-title":"Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor","volume":"308","author":"Chen","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.cbi.2008.12.005_bib28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1124\/mol.62.3.737","article-title":"Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site","volume":"62","author":"Ferguson","year":"2002","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.cbi.2008.12.005_bib29","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1124\/jpet.105.098160","article-title":"Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor","volume":"317","author":"Faucette","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279708006674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279708006674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:17:34Z","timestamp":1757855854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279708006674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":29,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0009279708006674"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2008.12.005","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro assessment of P450 induction potential of novel chemopreventive agents SR13668, 9-cis-UAB30, and pentamethychromanol in primary cultures of human hepatocytes","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2008.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ireland Ltd. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}